Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06093633 · ClinicalTrials.gov registry record
A Prospective Study to Evaluate the WP in Comparison to PSG in Patients Suspected of Sleep Disorders
A clinical trial of Sleep Disorder, sponsored by Itamar-Medical, Israel.
- Recruiting
- Registry status
- 600
- Enrollment target
- 3
- Study locations
NCT06093633: Recruiting study of Sleep Disorder, sponsored by Itamar-Medical, Israel.
NCT06093633 is a study of Sleep Disorder that is actively recruiting participants, run by Itamar-Medical, Israel. The registered enrollment target is 600 participants, above the 135-participant average among 22 other Sleep Disorder trials with a reported enrollment target (344% higher). The trial reports 3 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06093633, a study of Sleep Disorder, is actively recruiting participants, sponsored by Itamar-Medical, Israel.
- RECRUITING
- Registry status
- 600 participants
- Enrollment target
- 3
- Study locations
Study Summary
The current study is a prospective blinded study to collect data regarding the performance of the WP device in detecting sleep disorders. For that purpose, the WP with finger probe and chest sensor will be worn by the subject simultaneous to PSG in a sleep study at the clinical sleep lab. A PSG system will be recording the PSG data.
Primary Outcome
Compares the results of the automatically scored AHI of the WP to the manually scored AHI of the PSG (Gold Standard). AHI is the average number of apnea and hypopnea events per hour of sleep
Conditions Studied
Study Locations (3)
Maryland
- Johns Hopkins Bayview Asthma and Allergy Center - Baltimore
- University of Maryland St. Joseph Medical Group, Pulmonary Care & Sleep Medicine - Towson
Other
- Tel-Aviv Medical Center - Tel Aviv
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 600 participants |
| Start Date | 2022-09-19 |
| Est. Completion | 2025-10-01 |
What NCT06093633 shows while recruiting
NCT06093633 is an observational study that tracks outcomes without assigning an intervention. The registered 600 participants enrollment target is mid-sized for trials with a published cap, above the 135-participant average among 22 other Sleep Disorder trials with a reported enrollment target (344% higher).
The record links to 1 condition, with Sleep Disorder appearing as the primary indexed condition, and to 0 interventions.
NCT06093633 reports a single indexed study location in Maryland, Other.
Frequently Asked Questions
What is clinical trial NCT06093633 about?
NCT06093633 is a clinical study titled "A Prospective Study to Evaluate the WP in Comparison to PSG in Patients Suspected of Sleep Disorders". The current study is a prospective blinded study to collect data regarding the performance of the WP device in detecting sleep disorders. For that purpose, the WP with finger probe and chest sensor will be worn by the subject simultaneous to PSG in a sleep study at the clinical sleep lab. A PSG syst...
What is the current status of trial NCT06093633?
This trial is currently recruiting. The enrollment target is 600 participants. The study started on 2022-09-19. Estimated completion is 2025-10-01.
What conditions does trial NCT06093633 study?
This clinical trial studies the following conditions: Sleep Disorder.
Who is sponsoring clinical trial NCT06093633?
This trial is sponsored by Itamar-Medical, Israel, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06093633 being conducted?
This trial has 3 study locations across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sleep Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06093633's enrollment target sits among peer trials
600 1st of 22 higher than 22 of 22 other Sleep Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Sleep Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Evaluating the Effects of Tasimelteon in Individuals With Autism Spectrum Disorder (ASD) and Sleep Disturbances
RECRUITING · Phase 3
-
Study of Disrupted Sleep in Somali Americans
RECRUITING
-
Do Endotypes Predict Response and Sequelae in OSA Patients
RECRUITING · Phase 2
-
NIA_Improving Function and Well-being by Improving Patient Memory: Transdiagnostic Sleep and Circadian Treatment
RECRUITING · NA
-
Baker Gordon Syndrome Natural History Study
RECRUITING
-
Home Apnea Testing in CHildren Trial
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00004317 · 600 participants · Phase 4
Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis
- NCT00209235 · 600 participants · NA
Albright Hereditary Osteodystrophy: Natural History, Growth, and Cognitive/Behavioral Assessments
- NCT01473784 · 600 participants · NA
Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck
- NCT01866371 · 600 participants
High Resolution Retinal Imaging
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI